Antje Canisius

541 total citations
11 papers, 319 citations indexed

About

Antje Canisius is a scholar working on Immunology, Rheumatology and Molecular Biology. According to data from OpenAlex, Antje Canisius has authored 11 papers receiving a total of 319 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Immunology, 5 papers in Rheumatology and 4 papers in Molecular Biology. Recurrent topics in Antje Canisius's work include Neutrophil, Myeloperoxidase and Oxidative Mechanisms (5 papers), Systemic Lupus Erythematosus Research (5 papers) and Platelet Disorders and Treatments (3 papers). Antje Canisius is often cited by papers focused on Neutrophil, Myeloperoxidase and Oxidative Mechanisms (5 papers), Systemic Lupus Erythematosus Research (5 papers) and Platelet Disorders and Treatments (3 papers). Antje Canisius collaborates with scholars based in Germany, United States and Japan. Antje Canisius's co-authors include Karl J. Lackner, Nadine Müller‐Calleja, Dennis Strand, Davit Manukyan, Michael Torzewski, Heidi Rossmann, Fei Cheng, Friederike Häuser, Markus P. Radsak and Pamela Stein and has published in prestigious journals such as PLoS ONE, Annals of the Rheumatic Diseases and European Journal of Immunology.

In The Last Decade

Antje Canisius

11 papers receiving 315 citations

Peers

Antje Canisius
Qing Cai China
Erin Stevens United States
Marta Amaral Portugal
B. W. Kirkham Australia
Qing Cai China
Antje Canisius
Citations per year, relative to Antje Canisius Antje Canisius (= 1×) peers Qing Cai

Countries citing papers authored by Antje Canisius

Since Specialization
Citations

This map shows the geographic impact of Antje Canisius's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antje Canisius with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antje Canisius more than expected).

Fields of papers citing papers by Antje Canisius

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Antje Canisius. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antje Canisius. The network helps show where Antje Canisius may publish in the future.

Co-authorship network of co-authors of Antje Canisius

This figure shows the co-authorship network connecting the top 25 collaborators of Antje Canisius. A scholar is included among the top collaborators of Antje Canisius based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Antje Canisius. Antje Canisius is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Müller‐Calleja, Nadine, et al.. (2023). Rapid translocation of intracellular toll‐like receptors depends on endosomal NADPH oxidase. European Journal of Immunology. 53(9). e2250271–e2250271. 3 indexed citations
2.
Müller‐Calleja, Nadine, Antje Canisius, Martin F. Sprinzl, et al.. (2021). Pathogenic lipid‐binding antiphospholipid antibodies are associated with severity of COVID‐19. Journal of Thrombosis and Haemostasis. 19(9). 2335–2347. 29 indexed citations
3.
Müller‐Calleja, Nadine, et al.. (2019). Induction of tissue factor expression by anti-β2-glycoprotein I is mediated by tumor necrosis factor α. Journal of Thrombosis and Thrombolysis. 49(2). 228–234. 6 indexed citations
4.
Müller‐Calleja, Nadine, et al.. (2019). Platelet Activation by Antiphospholipid Antibodies Depends on Epitope Specificity and is Prevented by mTOR Inhibitors. Thrombosis and Haemostasis. 119(7). 1147–1153. 25 indexed citations
5.
Müller‐Calleja, Nadine, et al.. (2017). Antiphospholipid antibody‐induced cellular responses depend on epitope specificity : implications for treatment of antiphospholipid syndrome. Journal of Thrombosis and Haemostasis. 15(12). 2367–2376. 24 indexed citations
6.
Cheng, Fei, Kurt Reifenberg, Antje Canisius, et al.. (2016). Combined B, T and NK Cell Deficiency Accelerates Atherosclerosis in BALB/c Mice. PLoS ONE. 11(8). e0157311–e0157311. 7 indexed citations
7.
Müller‐Calleja, Nadine, Davit Manukyan, Antje Canisius, Dennis Strand, & Karl J. Lackner. (2016). Hydroxychloroquine inhibits proinflammatory signalling pathways by targeting endosomal NADPH oxidase. Annals of the Rheumatic Diseases. 76(5). 891–897. 83 indexed citations
8.
Müller‐Calleja, Nadine, et al.. (2015). Cofactor-independent antiphospholipid antibodies activate the NLRP3-inflammasome via endosomal NADPH-oxidase: implications for the antiphospholipid syndrome. Thrombosis and Haemostasis. 113(5). 1071–1083. 42 indexed citations
9.
10.
Canisius, Antje, et al.. (2013). Endosomal NADPH-oxidase is critical for induction of the tissue factor gene in monocytes and endothelial cells. Thrombosis and Haemostasis. 109(3). 525–531. 40 indexed citations
11.
Torzewski, Michael, et al.. (2009). Investigation of Sudan IV staining areas in aortas of infants and children: Possible prelesional stages of atherogenesis. Atherosclerosis. 206(1). 159–167. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026